Investor Toolbox
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
MRNA Coverage
Event
Moderna, Inc (MRNA) Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission
Feb 18, 2026
Event
Moderna, Inc (MRNA) Moderna Receives European Commission Marketing Authorization for COVID-19 Vaccine mNEXSPIKE
Feb 17, 2026
News
Moderna Q4 2025 net loss narrows; revenue drops 30%
Feb 16, 2026
Event
Moderna, Inc (MRNA) Sec Form 8K
Feb 14, 2026
News
Moderna Reports 4Q Revenue Of $678 Million, Projects 2026 Growth
Feb 13, 2026
Transcript
Moderna, Inc (MRNA) Q2 2022 Earnings Call Transcript
Jan 27, 2026
Transcript
Moderna, Inc (MRNA) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
Moderna, Inc (MRNA) Q3 2025 Earnings Call Transcript
Jan 22, 2026